Stocks and Investing Stocks and Investing
Tue, January 2, 2024
[ 12:00 AM ] - WOPRAI
Yanan Zhu Upgraded (VYGR) to Buy and Increased Target to $14 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Henry Coffey Maintained (WD) at Buy with Increased Target to $130 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Matthew Blair Upgraded (WLK) to Hold on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (WFC) at Buy with Increased Target to $66 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (BIOR) at Strong Buy and Held Target at $50 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Brent Bracelin Downgraded (BL) to Sell and Increased Target to $60 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Ken Gawrelski Upgraded (BKNG) to Hold on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Linda Tsai Upgraded (AMH) to Strong Buy and Increased Target to $41 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Eric Wold Maintained (AMC) at Hold with Decreased Target to $12 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (ALLY) at Hold with Increased Target to $43 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Jason Gerberry Maintained (ALKS) at Hold with Increased Target to $29 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (BAC) at Buy with Increased Target to $43 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Vincent Caintic Upgraded (AXP) to Hold and Held Target at $193 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Tim Long Maintained (AXON) at Buy with Increased Target to $296 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
George Staphos Downgraded (BALL) to Sell and Decreased Target to $59 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (ADBE) at Buy with Increased Target to $705 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Meta Marshall Maintained (ANET) at Buy with Increased Target to $272 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Craig Ellis Upgraded (AOSL) to Strong Buy and Increased Target to $34 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
George Staphos Downgraded (AVY) to Sell and Held Target at $208 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Andrew Rosivach Downgraded (AVB) to Hold on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Brent Bracelin Downgraded (AVDX) to Hold and Increased Target to $13 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Patrick Trucchio Reiterated (ATAI) at Strong Buy and Held Target at $20 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Eric Wold Downgraded (BC) to Hold and Held Target at $106 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Kate McShane Maintained (BBWI) at Strong Buy on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Marc Riddick Downgraded (CBZ) to Hold and Held Target at $63 on, Jan 2nd, 2024
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (C) at Hold with Increased Target to $63 on, Jan 2nd, 2024
Fri, December 29, 2023
[ 12:00 AM ] - WOPRAI
Benjamin Gerlinger Maintained (CADE) at Hold with Increased Target to $32 on, Dec 29th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Harrigan Maintained (ATUS) at Strong Buy with Decreased Target to $5 on, Dec 29th, 2023
[ 12:00 AM ] - WOPRAI
Sumant Kulkarni Initiated (ANVS) at Strong Buy and Held Target at $36 on, Dec 29th, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $9 on, Dec 29th, 2023

Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $9 on, Dec 29th, 2023


Published on 2024-10-28 08:08:26 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $9 on, Dec 29th, 2023.

Raghuram has made no other calls on ACRS in the last 4 months.



There are 4 other peers that have a rating on ACRS. Out of the 4 peers that are also analyzing ACRS, 3 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Alex Thompson of "Stifel" Maintained at Hold with Decreased Target to $1 on, Monday, December 18th, 2023
  • Louise Chen of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Tuesday, November 14th, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Monday, November 13th, 2023


This is the rating of the analyst that currently disagrees with Raghuram

  • Gavin Clark-Gartner of "Evercore ISI Group" Initiated at Buy and Held Target at $22 on, Tuesday, October 3rd, 2023
Contributing Sources